According to the function of GSST1 and GSTM1 in the detoxification of exogenous compounds, the individuals carrying deletions have an increased risk for several cancers (colorectal and chronic myeloid leukemia) and toxicities related to medications [35–39]. Here, GSTM1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.